Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Treatment for Restless Legs Syndrome [Internet].

Wilt TJ, MacDonald R, Ouellette J, Tacklind J, Khawaja I, Rutks I, Butler M, Fink HA.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 Nov.

2.

Restless legs syndrome.

Leschziner G, Gringras P.

BMJ. 2012 May 23;344:e3056. doi: 10.1136/bmj.e3056. Review. No abstract available.

PMID:
22623643
3.

Pramipexole versus dual release levodopa in restless legs syndrome: a double blind, randomised, cross-over trial.

Bassetti CL, Bornatico F, Fuhr P, Schwander J, Kallweit U, Mathis J; Swiss RLS study group.

Swiss Med Wkly. 2011 Nov 21;141:w13274. doi: 10.4414/smw.2011.13274.

4.

Clinical efficacy and safety of IV ferric carboxymaltose (FCM) treatment of RLS: a multi-centred, placebo-controlled preliminary clinical trial.

Allen RP, Adler CH, Du W, Butcher A, Bregman DB, Earley CJ.

Sleep Med. 2011 Oct;12(9):906-13. doi: 10.1016/j.sleep.2011.06.009. Epub 2011 Oct 5.

PMID:
21978726
5.

Bupropion and restless legs syndrome: a randomized controlled trial.

Bayard M, Bailey B, Acharya D, Ambreen F, Duggal S, Kaur T, Rahman ZU, Roller K, Tudiver F.

J Am Board Fam Med. 2011 Jul-Aug;24(4):422-8. doi: 10.3122/jabfm.2011.04.100173.

6.

Long-term safety and efficacy of rotigotine transdermal patch for moderate-to-severe idiopathic restless legs syndrome: a 5-year open-label extension study.

Oertel W, Trenkwalder C, Beneš H, Ferini-Strambi L, Högl B, Poewe W, Stiasny-Kolster K, Fichtner A, Schollmayer E, Kohnen R, García-Borreguero D; SP710 study group.

Lancet Neurol. 2011 Aug;10(8):710-20. doi: 10.1016/S1474-4422(11)70127-2. Epub 2011 Jun 24.

PMID:
21705273
7.

A randomized, double-blind, placebo-controlled study to assess the efficacy and tolerability of gabapentin enacarbil in subjects with restless legs syndrome.

Lee DO, Ziman RB, Perkins AT, Poceta JS, Walters AS, Barrett RW; XP053 Study Group.

J Clin Sleep Med. 2011 Jun 15;7(3):282-92. doi: 10.5664/JCSM.1074.

8.

Randomized polysomnography study of gabapentin enacarbil in subjects with restless legs syndrome.

Winkelman JW, Bogan RK, Schmidt MH, Hudson JD, DeRossett SE, Hill-Zabala CE.

Mov Disord. 2011 Sep;26(11):2065-72. doi: 10.1002/mds.23771. Epub 2011 May 24.

PMID:
21611981
9.

Restless legs syndrome (RLS) augmentation associated with dopamine agonist and levodopa usage in a community sample.

Allen RP, Ondo WG, Ball E, Calloway MO, Manjunath R, Higbie RL, Lee MR, Nisbet PA.

Sleep Med. 2011 May;12(5):431-9. doi: 10.1016/j.sleep.2011.03.003. Epub 2011 Apr 13.

PMID:
21493132
10.

Assessing the Applicability of Studies When Comparing Medical Interventions.

Atkins D, Chang S, Gartlehner G, Buckley DI, Whitlock EP, Berliner E, Matchar D.

Methods Guide for Effectiveness and Comparative Effectiveness Reviews [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2008-.
2010 Dec 30.

11.

Impact of short daily hemodialysis on restless legs symptoms and sleep disturbances.

Jaber BL, Schiller B, Burkart JM, Daoui R, Kraus MA, Lee Y, Miller BW, Teitelbaum I, Williams AW, Finkelstein FO; FREEDOM Study Group.

Clin J Am Soc Nephrol. 2011 May;6(5):1049-56. doi: 10.2215/CJN.10451110. Epub 2011 Mar 17.

12.

Dopamine agonists for restless legs syndrome.

Scholz H, Trenkwalder C, Kohnen R, Riemann D, Kriston L, Hornyak M.

Cochrane Database Syst Rev. 2011 Mar 16;(3):CD006009. doi: 10.1002/14651858.CD006009.pub2. Review.

PMID:
21412893
13.

Efficacy and augmentation during 6 months of double-blind pramipexole for restless legs syndrome.

Högl B, Garcia-Borreguero D, Trenkwalder C, Ferini-Strambi L, Hening W, Poewe W, Brenner SS, Fraessdorf M, Busse M, Albrecht S, Allen RP.

Sleep Med. 2011 Apr;12(4):351-60. doi: 10.1016/j.sleep.2010.12.007. Epub 2011 Feb 26.

PMID:
21354368
14.

Algorithms for the diagnosis and treatment of restless legs syndrome in primary care.

Garcia-Borreguero D, Stillman P, Benes H, Buschmann H, Chaudhuri KR, Gonzalez Rodríguez VM, Högl B, Kohnen R, Monti GC, Stiasny-Kolster K, Trenkwalder C, Williams AM, Zucconi M.

BMC Neurol. 2011 Feb 27;11:28. doi: 10.1186/1471-2377-11-28.

15.

Levodopa for restless legs syndrome.

Scholz H, Trenkwalder C, Kohnen R, Riemann D, Kriston L, Hornyak M.

Cochrane Database Syst Rev. 2011 Feb 16;(2):CD005504. doi: 10.1002/14651858.CD005504.pub2. Review.

PMID:
21328278
16.

Prevalence and disease burden of primary restless legs syndrome: results of a general population survey in the United States.

Allen RP, Bharmal M, Calloway M.

Mov Disord. 2011 Jan;26(1):114-20. doi: 10.1002/mds.23430. Epub 2010 Nov 10.

PMID:
21322022
17.

Non-pharmacological management of periodic limb movements during hemodialysis session in patients with uremic restless legs syndrome.

Giannaki CD, Sakkas GK, Hadjigeorgiou GM, Karatzaferi C, Patramani G, Lavdas E, Liakopoulos V, Koutedakis Y, Stefanidis I.

ASAIO J. 2010 Nov-Dec;56(6):538-42. doi: 10.1097/MAT.0b013e3181f1cc04.

PMID:
21245801
18.

A 52-week study of gabapentin enacarbil in restless legs syndrome.

Ellenbogen AL, Thein SG, Winslow DH, Becker PM, Tolson JM, Lassauzet ML, Chen D.

Clin Neuropharmacol. 2011 Jan-Feb;34(1):8-16. doi: 10.1097/WNF.0b013e3182087d48.

PMID:
21242741
19.

A 10-year, longitudinal assessment of dopamine agonists and methadone in the treatment of restless legs syndrome.

Silver N, Allen RP, Senerth J, Earley CJ.

Sleep Med. 2011 May;12(5):440-4. doi: 10.1016/j.sleep.2010.11.002. Epub 2011 Jan 15.

PMID:
21239226
20.

Ropinirole improves depressive symptoms and restless legs syndrome severity in RLS patients: a multicentre, randomized, placebo-controlled study.

Benes H, Mattern W, Peglau I, Dreykluft T, Bergmann L, Hansen C, Kohnen R, Banik N, Schoen SW, Hornyak M.

J Neurol. 2011 Jun;258(6):1046-54. doi: 10.1007/s00415-010-5879-7. Epub 2010 Dec 28.

PMID:
21188406

Supplemental Content

Support Center